Ressources

We sought to determine the prevalence of health care avoidance and its association with emergency department use among PWUD and examine patient-reported nonmedical qualities of health care (“respon

In this exploratory analysis, we investigated whether changes in the unregulated opioid drug supply are associated with income assistance payment weeks.

This study evaluated disparities in naloxone prescribing for patients who presented after opioid overdose in a large health system.

Establish standards of conduct for our interactions and relationships at work, as they relate to substance use and its intersections.

The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who use drugs by impacting social, community, and structural factors.

Clinical experience indicates that people who inject drugs (PWID) are hospitalized frequently for infectious diseases, but little is known about outcomes when admitted.

This study investigates the use of stigmatizing and destigmatizing language in four Twitter communities: Medical, Public Health, Epidemiology, and Mental Health

This article analyzes the implementation of Montreal SIS and discusses how the organizational aspects of SIS produce the contexts for drug injection.

This study, which we conducted in the Netherlands, assessed the barriers to and facilitators of accessibility to substance use treatment for non-service users with substance use disorders.

We aimed to determine whether the risk of psychotic events increases immediately after initiation of methylphenidate treatment or, in the longer term, 1 year after treatment initiation in adolescen

We conducted a systematic review and meta-analysis to evaluate usefulness of an agonist approach as treatment of (psycho)stimulant use disorder (PSUD).

We examined the impact of the publicly funded Ontario Naloxone Program for Pharmacies (ONPP), implemented in June 2016, on provincial rates of opioid overdose deaths.

This study aimed to characterize the prevalence of and the factors associated with a perceived decline in the quality of drugs during the COVID-19 pandemic among community-recruited cohorts of PWUD